Hikma lowers medium-term profit forecast on margin pressures
06/11/2025 07:26
Nov 6 (Reuters) - Hikma Pharmaceuticals HIK.L lowered its medium-term core operating profit expectations on Thursday due to margin pressures in its injectables unit, and also announced that the head of the unit will step down. The company now expects medium-term core operating profit to grow in the range of 5% to 7%, down from its previous outlook of 7% to 9%. (Reporting by Unnamalai L in Bengaluru; Editing by Janane Venkatraman) ((Unnamalai.L@thomsonreuters.com;))